{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:37:10Z","timestamp":1725694630724},"publisher-location":"Vienna","reference-count":28,"publisher":"Springer Vienna","isbn-type":[{"type":"print","value":"9783211822616"},{"type":"electronic","value":"9783709191354"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/978-3-7091-9135-4_19","type":"book-chapter","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T20:56:03Z","timestamp":1343508963000},"page":"119-124","source":"Crossref","is-referenced-by-count":0,"title":["Parkinsonian features in advanced Down\u2019s syndrome"],"prefix":"10.1007","author":[{"given":"P.","family":"Vieregge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ziemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Piosinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Freudenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"K\u00f6mpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"19_CR1","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/WNL.35.11.1544","volume":"35","author":"HC Chui","year":"1985","unstructured":"Chui HC, Teng EL, Henderson VW, Moy AC (1985) Clinical subtypes of dementia of the Alzheimer type. Neurology 35: 1544\u20131550","journal-title":"Neurology"},{"key":"19_CR2","first-page":"89","volume":"91","author":"G Cohen","year":"1983","unstructured":"Cohen G (1983) The pathobiology of Parkinson\u2019s disease: biochemical aspects of dopamine neuron senescence. J Neural Transm [Suppl ] 91: 89\u2013103","journal-title":"J Neural Transm [Suppl ]"},{"key":"19_CR3","first-page":"153","volume-title":"Recent developments in Parkinsons disease","author":"DA Drachman","year":"1975","unstructured":"Drachman DA, Stahl S (1975) Extrapyramidal dementia and levodopa. Lancet is 809 Fahn S, Elton RL, and members of the UPDRS development committee Unified Parkinson\u2019s disease rating scale (1987). In: Fahn S, Marsden CD, Caine DB, Goldstein M (eds) Recent developments in Parkinsons disease, vol 2. Macmillan Health Care Information, Florham Park NJ, pp 153\u2013167"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jnnp.52.2.193","volume":"52","author":"WRG Gibb","year":"1989","unstructured":"Gibb WRG, Mountjoy CQ, Mann DMA, Lees AJ (1989) The substantia nigra and ventral tegmental area in Alzheimer\u2019s disease and Down\u2019s syndrome. J Neurol Neurosurg Psychiatry 52: 193\u2013200","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"19_CR5","doi-asserted-by":"crossref","unstructured":"Goate AM, Haynes AR, Owen MJ, Farrall M, James LA, Lai LYC, Mullan MJ, Rogues P, Rossor MN, Williamson R, Hardy JA (1989) Predisposing locus for Alzheimer\u2019s disease on chromosome 21. Lancet is 352\u2013355","DOI":"10.1016\/S0140-6736(89)91725-X"},{"key":"19_CR6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.39.12.1589","volume":"39","author":"A Hofman","year":"1989","unstructured":"Hofman A, Schulte W, Tanja TA, van Duijn CM, Haaxma R, Lameris AJ, Otten VM, Saan RJ (1989) History of dementia and Parkinson\u2019s disease in 1st-degree relatives of patients with Alzheimer\u2019s disease. Neurology 39: 1589\u20131592","journal-title":"Neurology"},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ana.410160418","volume":"16","author":"WC Koller","year":"1984","unstructured":"Koller WC, Wilson RS, Glatt SL, Fox JH (1984) Motor signs are infrequent in dementia of the Alzheimer type. Ann Neurol 16: 514\u2013516","journal-title":"Ann Neurol"},{"key":"19_CR8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","volume":"46","author":"F Lai","year":"1989","unstructured":"Lai F, Williams RS (1989) A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46: 849\u2013853","journal-title":"Arch Neurol"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/archneur.1986.00520070020010","volume":"43","author":"J Leverenz","year":"1986","unstructured":"Leverenz J, Sumi SM (1986) Parkinson\u2019s disease in patients with Alzheimer\u2019s disease. Arch Neurol 43: 662\u2013664","journal-title":"Arch Neurol"},{"key":"19_CR10","first-page":"237","volume":"12","author":"D Loesch-Mdzewska","year":"1968","unstructured":"Loesch-Mdzewska D (1968) Some aspects of the neurology of Down\u2019s syndrome. J Ment Defic Res 12: 237\u2013246","journal-title":"J Ment Defic Res"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0270-3092(82)90017-0","volume":"3","author":"IT Lott","year":"1982","unstructured":"Lott IT, Lai F (1982) Dementia in Down\u2019s syndrome: observations from a neurologic clinic. Appl Res Ment Retard 3: 233\u2013239","journal-title":"Appl Res Ment Retard"},{"key":"19_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-510X(87)90223-1","volume":"80","author":"DMA Mann","year":"1987","unstructured":"Mann DMA, Yates PO, Marcyniuk B, Ravindra CR (1987) Loss of neurons from cortical and subcortical areas in Down\u2019s syndrome patients at middle age. J Neurol. Sci 80: 79\u201389","journal-title":"J Neurol. Sci"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0022-510X(88)90108-6","volume":"86","author":"RJ Marttila","year":"1988","unstructured":"Marttila RJ, Lorentz H, Rinne UK (1988) Oxygen toxicity protecting enzymes in Parkinson\u2019s disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 86: 321\u2013331","journal-title":"J Neurol. Sci"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.35.4.453","volume":"35","author":"R Mayeux","year":"1985","unstructured":"Mayeux R, Stern Y, Spanton S (1985) Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 35: 453\u2013461","journal-title":"Neurology"},{"key":"19_CR15","first-page":"377","volume":"87","author":"NA Miniszek","year":"1983","unstructured":"Miniszek NA (1983) Development of Alzheimer disease in Down\u2019s syndrome individuals. Am J Ment Defic 87: 377\u2013385","journal-title":"Am J Ment Defic"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1212\/WNL.34.8.1114","volume":"34","author":"PK M\u00f6ls\u00e4","year":"1984","unstructured":"M\u00f6ls\u00e4 PK, Marttila RJ, Rinne UK (1984) Extrapyramidal signs in Alzheimer\u2019s disease. Neurology 34: 1114\u20131116","journal-title":"Neurology"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/archneur.1989.00520420071025","volume":"46","author":"JC Morris","year":"1989","unstructured":"Morris JC, Drazner M, Fulling K, Grant EA, Goldring J (1989) Clinical and pathological aspects of Parkinsonism in Alzheimer\u2019s disease. Arch Neurol 46: 651\u2013657","journal-title":"Arch Neurol"},{"key":"19_CR18","first-page":"606","volume":"75","author":"D Owens","year":"1971","unstructured":"Owens D, Dawson JC, Losin S (1971) Alzheimer\u2019s disease in Down\u2019s syndrome. Am J Ment Defic 75: 606\u2013612","journal-title":"Am J Ment Defic"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000114608","volume":"12","author":"J Pearce","year":"1974","unstructured":"Pearce J (1974) The extrapyramidal disorder of Alzheimer\u2019s disease. Eur Neurol 12: 94\u2013103","journal-title":"Eur Neurol"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1471-4159.1989.tb11759.x","volume":"53","author":"H Saggu","year":"1989","unstructured":"Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989) A selective increase in particulate superoxide dismutase activity in Parkinsonian sub-stantia nigra. J Neurochem 53: 692\u2013697","journal-title":"J Neurochem"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/ana.410220608","volume":"22","author":"BS Schoenberg","year":"1987","unstructured":"Schoenberg BS, Kokmen E, Okazaki H (1987) Alzheimer\u2019s disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 22: 724\u2013729","journal-title":"Ann Neurol"},{"key":"19_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1600-0404.1982.tb03117.x","volume":"65","author":"R Sulkava","year":"1982","unstructured":"Sulkava R (1982) Alzheimer\u2019s disease and senile dementia of Alzheimer type. Acta Neurol Scand 65: 636\u2013650","journal-title":"Acta Neurol Scand"},{"key":"19_CR23","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0140-6736(89)91580-8","volume":"11","author":"PJ Tyrell","year":"1989","unstructured":"Tyrell PJ, Rossor MN (1989) Extrapyramidal signs in dementia of Alzheimer type. Lancet 11: 920","journal-title":"Lancet"},{"key":"19_CR24","first-page":"99","volume":"18","author":"RM Veall","year":"1974","unstructured":"Veall RM (1974) The prevalence of epilepsy among mongols related to age. J Ment Defic Res 18: 99\u2013106","journal-title":"J Ment Defic Res"},{"key":"19_CR25","first-page":"619","volume":"13","author":"KE Wisniewski","year":"1978","unstructured":"Wisniewski KE, Howe J, Williams CG, Wisniewski HM (1978) Precocious aging and dementia in patients with Down\u2019s syndrome. Biol Psychiatry 13: 619\u2013627","journal-title":"Biol Psychiatry"},{"key":"19_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.410170310","volume":"17","author":"KE Wisniewski","year":"1985","unstructured":"Wisniewski KE, Wisniewski HM, Wen GY (1985b) Occurrence of neuropathological changes and dementia of Alzheimer\u2019s disease in Down\u2019s syndrome. Ann Neurol 17: 278\u2013282","journal-title":"Ann Neurol"},{"key":"19_CR27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.35.7.957","volume":"35","author":"KE Wisniewski","year":"1985","unstructured":"Wisniewski KE, Dalton AJ, CrapperMcLachlan DR, Wen GY, Wisniewski HM (1985b) Alzheimer\u2019s disease in Down\u2019s syndrome: clinico-pathologic studies. Neurology 35: 957\u2013961","journal-title":"Neurology"},{"key":"19_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-0447.1988.tb05074.x","volume":"77","author":"LN Yatham","year":"1988","unstructured":"Yatham LN, McHale PA, Kinsella A (1988) Down\u2019s syndrome and its association with Alzheimer\u2019s disease. Acta Psychiatr Scand 77: 38\u201341","journal-title":"Acta Psychiatr Scand"}],"container-title":["Age-associated Neurological Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-9135-4_19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T09:56:08Z","timestamp":1606125368000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-9135-4_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"ISBN":["9783211822616","9783709191354"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-9135-4_19","relation":{},"subject":[],"published":{"date-parts":[[1991]]}}}